Decheng Capital Management III (Cayman)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $12.2M | Hold |
1,463,872
| – | – | 4.08% | 9 |
|
|
2023
Q2 | $19.5M | Hold |
1,463,872
| – | – | 6.11% | 5 |
|
|
2023
Q1 | $17M | Hold |
1,463,872
| – | – | 6.84% | 5 |
|
|
2022
Q4 | $12M | Hold |
1,463,872
| – | – | 4.48% | 9 |
|
|
2022
Q3 | $8.51M | Hold |
1,463,872
| – | – | 3.08% | 10 |
|
|
2022
Q2 | $6.47M | Hold |
1,463,872
| – | – | 2.45% | 13 |
|
|
2022
Q1 | $13.3M | Buy |
+1,463,872
| New | +$13.3M | 4.08% | 8 |
|